Alkermes develops innovative medicines that seek to address unmet needs of people living with serious mental illness, addiction and cancer. A fully-integrated, global biopharmaceutical company, with U.S. locations in Massachusetts and Ohio, and locations in Dublin and Athlone, Ireland, we apply our scientific expertise and proprietary technologies to develop products designed to make a meaningful difference in the way people manage their disease. Beyond our scientific pursuits, we actively and collaboratively advocate for the people affected by these serious diseases, and are committed to patient engagement, disease education and supporting policies that enable access to all approved treatment options.